Tyra Biosciences (TYRA) Current Leases (2020 - 2026)
Tyra Biosciences (TYRA) reported Current Leases of $488000.0 for Q1 2026, up 14.55% on a YoY basis from $426000.0 in Q1 2025, and up 3.39% quarter-over-quarter from $472000.0 in Q4 2025.
Tyra Biosciences (TYRA) Current Leases (2020 - 2026) Analysis & Trends
Tyra Biosciences has reported Current Leases for 7 years, with the latest figure at $488000.0 in Q1 2026.
- For the quarter ending Q1 2026, Current Leases rose 14.55% year-over-year to $488000.0; the trailing twelve-month figure through Mar 2026 stood at $488000.0 (up 14.55% YoY), and the FY2025 full-year result was $472000.0, up 14.56% from the prior year.
- Current Leases for Q1 2026 stood at $488000.0, up from $472000.0 in the prior quarter.
- The five-year high for Current Leases was $488000.0 in Q1 2026, with the low at $119000.0 in Q1 2022.
- Historically, Current Leases has averaged $298294.1 across 5 years, with a median of $370000.0 in 2024.
- Annual changes were most pronounced in 2022 — Current Leases plunged 30.69% — and 2024, when it soared 168.92%.
- Tyra Biosciences' Current Leases stood at $140000.0 in 2022, then surged by 100.0% to $280000.0 in 2023, then surged by 47.14% to $412000.0 in 2024, then advanced by 14.56% to $472000.0 in 2025, then rose by 3.39% to $488000.0 in 2026.
- The last three Current Leases figures came in at $488000.0 (Q1 2026), $472000.0 (Q4 2025), and $456000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 814,307.08 Bn | 814,307.05 Bn | - | 42,980.09 |
| 2 | Belite Bio | 55,320.00 Bn | 55,320.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,149.72 Bn | 17,149.72 Bn | - | 83,991.00 |
| 4 | Legend Biotech | 3,590.00 Bn | 3,589.71 Bn | 242.10 Mn | 7.40 Mn |
| 5 | Akari Therapeutics | 1,650.72 Bn | 1,650.72 Bn | - | - |
| 6 | Evaxion A | 1,522.09 Bn | 1,522.07 Bn | - | - |
| 7 | Psyence Biomedical | 229.39 Bn | 229.38 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 113.09 Bn | 105.85 Bn | 2.59 Bn | - |
| 9 | Abivax | 90.15 Bn | 90.15 Bn | - | - |
| 10 | Tyra Biosciences | 1.67 Bn | 1.67 Bn | - | 488,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 488,000.00 |
| Dec 31, 2025 | 472,000.00 |
| Sep 30, 2025 | 456,000.00 |
| Jun 30, 2025 | 441,000.00 |
| Mar 31, 2025 | 426,000.00 |
| Dec 31, 2024 | 412,000.00 |
| Sep 30, 2024 | 398,000.00 |
| Jun 30, 2024 | 383,000.00 |
| Mar 31, 2024 | 370,000.00 |
| Dec 31, 2023 | 280,000.00 |
| Sep 30, 2023 | 148,000.00 |
| Jun 30, 2023 | 144,000.00 |
| Mar 31, 2023 | 144,000.00 |
| Dec 31, 2022 | 140,000.00 |
| Sep 30, 2022 | 127,000.00 |
| Jun 30, 2022 | 123,000.00 |
| Mar 31, 2022 | 119,000.00 |
| Dec 31, 2021 | 202,000.00 |
| Sep 30, 2021 | 135,000.00 |
| Dec 31, 2020 | 142,000.00 |